Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to ...

A dual-action nanomaterial uses cancer’s own chemistry to destroy tumors while leaving healthy cells unharmed.

Researchers at the Johns Hopkins Kimmel Cancer Center have discovered how certain pathogenic bacteria in gut and breast ...

Scientists have uncovered a hidden partnership between pancreatic cancer and the nervous system. Support cells in the ...

Engineered yeast cells can mimic real cancer cells and be used to test new cancer immunotherapies much faster, benefiting patients.

A newly identified driver of melanoma growth not only promotes tumor blood supply but also helps tumors evade immune attack.

Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in ...

The National Cancer Institute has quietly moved a familiar and polarizing drug into its preclinical pipeline: ivermectin, ...

An Indian review reveals how macrophages are reprogrammed inside breast tumours, helping cancer grow and spread while opening new treatment pathways.

Professor Chad Mirkin found that the vaccine’s carefully organized structure dramatically boosts cancer-fighting immunity.